Acetyldigoxin

Star0

DB13691ExperimentalSmall molecule

Acetyldigoxin: Overview.

Mechanism: Pharmacologically active on Sodium/Potassium Transporting ATPase
Curator reviewed
Formula / weight: C₄₃H₆₆O₁₅ · 822.986 g/mol (avg)
Also known as: alpha-acetyldigoxin

Resolves to

Compound

UNIIQ28IFH7A50CAS5511-98-8ChEMBLCHEMBL2074725

Clinical / RWD

RxNorm199ATCC01AA02ATCC01AA52

Structure

InChIKeyHWKJSYYYURVNQU-DXJNJSHLSA-NSMILES

C[C@H]1O[C@H](C[C@H](OC(C)=O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CC[C@@H]5[C@@H]4C[C@@H](O)[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1,054Drug interactionsStructured to mechanism, not free text

1Marketed productAcross 1 country and 1 labeller

2ATC codesIncluding every combination product, plus 18 drug categories

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Acetyldigoxin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account